Search: onr:"swepub:oai:gup.ub.gu.se/82386" >
Diagnosis and treat...
Diagnosis and treatment of premenstrual dysphoria.
-
- Eriksson, Elias, 1956 (author)
- Gothenburg University,Göteborgs universitet,Institutionen för fysiologi och farmakologi, Avdelningen för farmakologi,Institute of Physiology and Pharmacology, Dept of Pharmacology
-
- Andersch, Björn (author)
- Gothenburg University,Göteborgs universitet,Institutionen för kvinnors och barns hälsa, Avdelningen för obstetrik och gynekologi,Institute for the Health of Women and Children, Dept of Obstetrics and Gynaecology
-
- Ho, Hoi-Por, 1962 (author)
- Gothenburg University,Göteborgs universitet,Institutionen för fysiologi och farmakologi, Avdelningen för farmakologi,Institute of Physiology and Pharmacology, Dept of Pharmacology
-
show more...
-
- Landén, Mikael, 1966 (author)
- Gothenburg University,Göteborgs universitet,Institutionen för klinisk neurovetenskap, Sektionen för psykiatri,Institute of Clinical Neurosciences, Section of Psychiatry
-
- Sundblad-Elverfors, Charlotta, 1959 (author)
- Gothenburg University,Göteborgs universitet,Institutionen för fysiologi och farmakologi, Avdelningen för farmakologi,Institute of Physiology and Pharmacology, Dept of Pharmacology
-
show less...
-
(creator_code:org_t)
- 2002
- 2002
- English.
-
In: The Journal of clinical psychiatry. - 0160-6689. ; 63 Suppl 7, s. 16-23
- Related links:
-
https://gup.ub.gu.se...
Abstract
Subject headings
Close
- Premenstrual dysphoria (PMD) is a severe form of premenstrual syndrome afflicting 5% to 10% of all fertile women. Cardinal symptoms--appearing regularly between ovulation and menstruation and disappearing within a few days after the onset of the bleeding--are depressed mood, tension, affect lability, and irritability. Of these symptoms, irritability is often the most prominent. Serotonin reuptake inhibitors (SRIs), but not nonserotonergic antidepressants, reduce the symptoms of PMD effectively. The onset of action of SRIs is much shorter when used for PMD than when used for depression, enabling women with PMD to restrict medication use to the luteal phase of the cycle (so-called intermittent treatment). The findings that SRIs are effective for PMD--and that sexual dysfunction is the most frequent side effect during long-term treatment--both lend support for the hypothesis that a major role for brain serotonin is to modulate sex steroid-driven behavior.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinska och farmaceutiska grundvetenskaper -- Farmakologi och toxikologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Basic Medicine -- Pharmacology and Toxicology (hsv//eng)
Keyword
- Adult
- Estrogens
- physiology
- Female
- Humans
- Medical Records
- Premenstrual Syndrome
- diagnosis
- drug therapy
- physiopathology
- Progesterone
- physiology
- Serotonin
- physiology
- Serotonin Uptake Inhibitors
- therapeutic use
- Sex Factors
- Treatment Outcome
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
To the university's database